SK Biopharmaceuticals. (326030.KQ) Q3 2024 Earnings

Aug 8Confirmed
Aug 2022
Q4 2023
Q2 2024
Q3 2024
-580
-283
14
311

Details

Expected EPS
106
Actual EPS
311
Surprise EPS
205
Surprise Percent
+192.44%

Description

⁨SK Biopharmaceuticals.⁩ (⁦326030.KQ⁩) has reported earnings of ⁦311⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts